Guardant Health Inc. (GH)
BMV
Closed
Aug 21, 2026
Day's Range
2,784.0052 wk Range
820.00Overview - GH - Guardant Health Inc.
Key Statistics
Valuation
Enterprise Value
6.33T
P/E (Trailing)
‪-838.55‬
PEG Ratio
‪-67.08‬
Price / Sales (TTM)
‪315.78‬
Price / Book
‪-1,659.74‬
EV / EBITDA
‪-869.18‬
Profitability
Gross Margin
‪65.38%‬
Profit Margin
‪-38.32%‬
Operating Margin
‪-38.24%‬
Return on Assets
‪-18.07%‬
Return on Equity
‪419.18%‬
Ownership
Shares Outstanding
133.61M
Float
129.39M
Held by Insiders
‪3.97%‬
Held by Institutions
‪100.91%‬
Price stats
Beta
‪1.58‬
50-Day Avg
‪2,560.28‬
200-Day Avg
‪2,144.72‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - GH - Guardant Health Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on BMV.
- GHBMVGuardant Health Inc.373.60BMarket Cap+70.55%52-week change-838.55P/E (Trailing)‪-38.32%‬Profit Margin
- TMOBMVThermo Fisher Scientific Inc.3.82TMarket Cap+11.55%52-week change34.13P/E (Trailing)‪15.03%‬Profit Margin
- DHRBMVDanaher Corporation2.59TMarket Cap-5.40%52-week change38.76P/E (Trailing)‪15.94%‬Profit Margin
- IDXXBMVIdexx Laboratories Inc.747.08BMarket Cap-27.10%52-week change39.06P/E (Trailing)‪25.03%‬Profit Margin
- IQVBMVIqvia Holdings Inc.720.87BMarket Cap+20.87%52-week change32.11P/E (Trailing)‪8.09%‬Profit Margin
- DIABMVSPDR Dow Jones Industrial Average ETF Trust701.07BMarket Cap+5.74%52-week change4.39P/E (Trailing)—Profit Margin
- ABMVAgilent Technologies Inc.663.71BMarket Cap+3.28%52-week change27.85P/E (Trailing)‪19.55%‬Profit Margin
Profile Summary - GH - Guardant Health Inc.
About
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
